Changes of Liver Function in 35 Patients Orally Taking Polygoin Multiflori Radix Preparations

doi:10.19803/j.1672-8629.2021.03.06

Abstract

Abstract: Objective To analyze the post-treatment changes of liver function in patients taking a conventional dosage of decoction and Chinese patent medicine containing Polygoni Multiflori Radix(PMR), and to determine the risk of liver injury in clinical application. Methods The clinical data on 35 cases who used decoction and Chinese patent medicine containing PMR was collected. Their liver function indexes, such as alanine aminotransferase(ALT), aspartate aminotransferase(AST), alkaline phosphatase(ALP),γ-glutamyl transpeptadase (GGT), total bilirubin(TBIL), direct bilirubin(DBIL) and indirect bilirubin(IBIL) , were detected. The patients were divided into two groups according to the normality of their liver function indexes before treatment and the incidence of liver injury after treatment was analyzed. Results There was no significant difference in levels of AST, ALP, GGT, TBIL, DBIL or IBIL after treatment（P>0.05）in patients who had normal liver function before treatment, but there was significant difference in ALT（P<0.05）that was in the normal range. Among patients who had abnormal liver function before treatment, there was also no significant difference in levels of ALP, GGT, TBIL or IBIL after treatment（P>0.05）, but some of their liver function indexes decreased after treatment. Conclusion Taking orally a conventional dosage of decoction and Chinese patent medicine containing PMR is relatively safe and has lower clinical risk of liver injury.

Key words: Polygoni Multiflori Radix, adverse event, liver function, liver injury

CLC Number:

R954.3R994.11

ZHOU Ming, FEI Zhanyang, ZHAO Jiuli, XUE Dan, LI Ming, LI Dengke, Wang Zijian, LI Yiqun, TANG Xuechun, SUN Zhenxiao. Changes of Liver Function in 35 Patients Orally Taking Polygoin Multiflori Radix Preparations[J]. Chinese Journal of Pharmacovigilance, 2021, 18(3): 235-239.

References

[1] National Pharmacopoeia Committee, SP. Pharmacopoeia of the People's Republic of China(中华人民共和国药典2020年版一部)[M]. Beijing: China Medical Science Press, 2020: 183-184.
[2] Zhang L, Yang XH, Sun ZX, et al.Retrospective study of adverse events of polygonum multiflorum and risk control[J]. China Journal of Chinese Materia Medica(中国中药杂志), 2009, 34(13): 1724-1729.
[3] Wang H, Yang J, Zhou LY, et al.Chemical compositions and pharmacological activities of polygoni multiflori radix[J]. Chinese Journal of Experimental Traditional Medical Formulae(中国实验方剂学杂志), 2019, 25(13): 192-205.
[4] Lin L, Ni B, Lin H, et al.Traditional usages, botany, phytochemistry, pharmacology and toxicology of Polygonum multiflorum Thunb.: A review[J]. J Ethnopharmacol, 2015, 159:158-183.
[5] Yang HL, Ge ZZ, Sun ZX.The latest progress in pharmacological research of polygoni multiflori radix[J]. Journal of Chinese Medicinal Materials(中药材), 2013, 36(10): 1713-1717.
[6] Song XB, Du XX, Guo XX, et al.Safety and risk factor analysis on polygoni multiflori radix based on ancient traditional chinese medicine literature[J]. China Journal of Chinese Materia Medica(中国中药杂志), 2015, 40(5): 985-988.
[7] Liu ZQ, Zhao GY.One poisoning case following excessive intake of polygonum multiflorum[J]. Chinese Journal of Postgraduates of Medicine(医师进修杂志), 1988(3): 31.
[8] Zhang L, Yang XH, Deng YY.Evaluation and consideration on safety information abroad of polygonum multiflorum and its preparations[J]. China Journal of Chinese Materia Medica(中国中药杂志), 2009, 34(18): 2414-2418.
[9] Sun ZX, Zhang L.Liver damage related to polygonum multiflorum and its preparations: domestic literature review and analysis[J]. Adverse Drug Reactions Journal(药物不良反应杂志), 2010, 12(1): 26-30.
[10] Liu Y, Wang W, Sun M, et al.Polygonum multiflorum-induced liver injury: clinical characteristics, risk factors, material basis, action mechanism and current challenges[J]. Front Pharmacol, 2019, 10: 1467.
[11] Dong H, Slain D, Cheng J, et al.Eighteen cases of liver injury following ingestion of polygonum multiflorum[J]. Complement Ther Med, 2014, 22(1): 70-74.
[12] Wang HZ, Li XH.Clinical analysis of 33 cases of drug induced liver injury caused by polygonum multiflorum thunb and its preparations[J]. Chinese Journal of Integrated Traditional and Western Medicine on Liver Diseases(中西医结合肝病杂志), 2018, 28(1): 25-27.
[13] Zhang M,Lin L, Lin H, et al.Interpretation the hepatotoxicity based on pharmacokinetics investigated through oral administrated different extraction parts of Polygonum multiflorum on rats[J]. Front Pharmacol, 2018, 9: 25.
[14] Tao LY, Gao YQ, Wang JR, et al.Research progress of clinical application and its related liver injury of polygonum multiflorum[J]. Hunan Journal of Traditional Chinese Medicine(湖南中医杂志), 2018, 34(11): 194-198.
[15] Wang J, Zhu Y, Bai Z, et al.Guidelines for the diagnosis and management of herb-induced liver injury[J]. Chin J Integr Med, 2018, 24: 696-706.
[16] Wu B, Liu LL.The significance of Biochemical indexes combined detection in the diagnosis of liver diseases[J]. China Continuing Medical Education(中国继续医学教育), 2019, 11(34): 103-105.
[17] Zhu Y, Liu SH, Wang JB, et al.Clinical analysis of drug-induced liver injury caused by polygonum multiflorum and its preparations[J]. Chinese Journal of Integrated Traditional and Western Medicine(中国中西医结合杂志), 2015, 35(12): 1442-1447.
[18] Guidelines for safe use of polygoni multiflori radix[J]. China Journal of Chinese Materia Medica(中国中药杂志), 2020, 45(5): 961-966.
[19] Chen CW.Drug-induced liver disease[J]. Chinese Hepatology(肝脏), 2012, 17(5): 297-300.
[20] Wang G, Liu Y, Hou XF, et al.Discussion on influence factors, mechanism and traditional Chinese medicine pathogenesis of idiosyncratic drug-induced liver injury[J]. China Journal of Chinese Materia Medica(中国中药杂志), 2017, 42(16): 3036-3043.
[21] Ma K, Zhang X, Jia H.CYP1A2 polymorphism in Chinese patients with acute liver injury induced by Polygonum multiflorum[J]. Genet Mol Res, 2014, 13(3): 5637-5643.
[22] Li D, Chen J, Ge Z, et al.Hepatotoxicity in rats induced by aqueous extract of polygoni multiflori radix, root of polygonum multiflorum related to the activity inhibition of CYP1A2 or CYP2E1[J]. Evid Based Complement Alternat Med, 2017, 2017: 9456785.
[23] Li C, Rao T, Chen X, et al.HLA-B*35:01 allele is a potential biomarker for predicting polygonum multiflorum-induced liver injury in humans[J]. Hepatology, 2019, 70(1): 346-357.